Serum Institute says in active talks with Indian govt around potential COVID-19 vaccines

  • Reuters
Serum Institute says in active talks with Indian govt around potential COVID-19 vaccines

MUMBAI, Nov 28 (Reuters) - Serum Institute of India (SII), the world's largest vaccine producer, is in active discussions with the Indian government on pricing and distribution of potential COVID-19 vaccines, said its Chief Executive Adar Poonawalla on Saturday.

His comments come following Indian Prime Minister Narendra Modi's visit to the Serum Institute of India's sprawling campus in the western city of Pune. L4N2IE01V

Serum Institute, the world's largest vaccine manufacturer, has partnered with global players including AstraZeneca AZN.L and Novavax Inc NVAX.O to run domestic trials on their vaccine candidates and produce the vaccines if they secure approvals.

Poonawalla said in the next few weeks SII plans to apply for emergency use authorization for AstraZeneca's COVID-19 vaccine candidate that he described as a "very good" option.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles